Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling
Crossref DOI link: https://doi.org/10.1007/s10495-017-1395-x
Published Online: 2017-07-04
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Hai-Jing
Yang, Zai-Xing
Dai, Xiao-Tian
Chen, Yong-Feng
Yang, He-Ping
Zhou, Xiang-Dong
Funding for this research was provided by:
Chinese National Science Foundation (81102857)
License valid from 2017-07-04